Type II toxin-antitoxin (TA) modules, which are important cellular regulators in prokaryotes, usually encode two proteins, a toxin that inhibits cell growth and a nontoxic and labile inhibitor (antitoxin) that binds to and neutralizes the toxin. Here, we demonstrate that the res-xre locus from Photorhabdus luminescens and other bacterial species function as bona fide TA modules in Escherichia coli. The 2.2 Å crystal structure of the intact Pseudomonas putida RES-Xre TA complex reveals an unusual 2:4 stoichiometry in which a central RES toxin dimer binds two Xre antitoxin dimers. The antitoxin dimers each expose two helix-turn-helix DNA-binding domains of the Cro repressor type, suggesting the TA complex is capable of binding the upstream promoter sequence on DNA. The toxin core domain shows structural similarity to ADP-ribosylating enzymes such as diphtheria toxin but has an atypical NAD + -binding pocket suggesting an alternative function. We show that activation of the toxin in vivo causes a depletion of intracellular NAD + levels eventually leading to inhibition of cell growth in E. coli and inhibition of global macromolecular biosynthesis. Both structure and activity are unprecedented among bacterial TA systems, suggesting the functional scope of bacterial TA toxins is much wider than previously appreciated.
Introduction
Bacterial toxin-antitoxin (TA) modules encode a toxin that inhibits cell growth when activated and a cognate antitoxin that neutralizes this activity under normal growth conditions. TA-encoded toxins most commonly inhibit translation or replication and are important for a range of bacterial survival mechanisms, including plasmid stabilization via post-segregationally killing, virus defense by abortive infection, multidrug tolerance (Harms et al., 2018) and virulence (Helaine et al., 2014; Lobato-Marquez et al., 2015) . Four major types of TA modules (type I-IV) have been described based on the nature of the antitoxin and the mechanism by which it counteracts the toxin (Harms et al., 2018) . Of these, the type II modules, which are the most widespread and best studied, encode two proteins, a metabolically stable toxin and an unstable antitoxin that forms a tight, nontoxic complex with the toxin. Upon activation, most type II toxins are active RNases that inhibit translation through degradation of essential RNA species. For example, toxins belonging to the RelE superfamily inhibit translation by cleavage of mRNA codons presented at the ribosomal A site (Pedersen et al., 2003; Neubauer et al., 2009) , while the MazF and HicA toxins cleave mRNAs independently of the ribosome (Zhang et al., 2003; Jørgensen et al., 2009) . The large VapC family of PIN domain toxins mediate site-specific cleavage of stable RNAs, including both rRNA and several tRNA isoforms (Winther and Gerdes, 2011; Sharp et al., 2012; Winther et al., 2013; Cruz et al., 2015; Winther et al., 2016) . Finally, a separate group of type II toxins, CcdB, ParE and FicT, are not nucleases but target replication by blocking DNA gyrase and/or topoisomerase IV (Bernard and Couturier, 1992; Miki et al., 1992; Roberts et al., 1994; Harms et al., 2015) .
Type II TA modules are remarkably abundant in some prokaryotic genomes (Pandey and Gerdes, 2005; Jørgensen et al., 2009; Xie et al., 2018) . For example, Mycobacterium tuberculosis strain H37Rv, a major human pathogen, encodes a stunning 88 putative TA modules (Ramage et al., 2009) . Likewise, the γ-proteobacterium, Photorhabdus luminescens, which is both an insect pathogen and symbiont of nematodes, was predicted to encode at least 66 TA modules (Jørgensen et al., 2009; Leplae et al., 2011) . P. luminescens has a complex life cycle (Clarke, 2014) , which may be one reason why its genome encodes such an extensive variety of anti-host effectors and virulence-associated toxins (Duchaud et al., 2003; Dowling, 2017) . But overall, it is largely unknown why some prokaryotic genomes seem to 'attract' such a large number of TA modules. According to the TA database (TADB 2.0), most of the TA modules identified in the genome of P. luminescens belong to well-characterized TA families, such as RelBE, HigBA, ParDE, VapBC, MazEF, CcdAB and HicBA (Xie et al., 2018) . However, a hitherto uncharacterized type II TA locus was also found, for which the putative toxin gene (plu2358) encodes a protein containing a so-called RES domain (Makarova et al., 2009) . The RES domain is biochemically and structurally uncharacterized and named after three conserved amino acids, arginine (R), glutamate (E) and serine (S) that were suggested to support a novel, metal-independent RNase activity (Makarova et al., 2009; Zhang et al., 2012) . RES domain homologs are abundant in both Gram-positive and Gram-negative bacteria and belong to a cluster of orthologous groups (COG5654) with unknown function (Tatusov et al., 2000) . The putative antitoxin gene (plu2357, COG5642) is also a conserved, uncharacterized protein predicted to contain an Xre (Xenobiotic response element) family helix-turn-helix (HTH) DNAbinding domain (Cro/C1 type), as well as a C-terminal domain of unknown function, DUF2384 (Makarova et al., 2009 ). Previously, it was shown that a RES toxin encoded by the α-proteobacterium, Sinorhizobium meliloti, is toxic when expressed in Escherichia coli and can be counteracted by its cognate Xre antitoxin (Milunovic et al., 2014) , suggesting that this locus (COG5654-COG5642, res-xre) constitutes a bona fide TA module. However, the cellular function of the RES toxin when activated, as well as structure and the antitoxic mechanism of the Xre antitoxin, remain unknown.
Here, we provide a thorough functional and structural analysis of the RES-Xre TA modules. We demonstrate that the RES toxin from several bacterial species reversibly inhibits cell growth in E. coli, and that expression of the Xre antitoxin neutralizes this toxicity. The 2.2 Å crystal structure of the intact Pseudomonas putida RES-Xre complex reveals an unusual 2:4 stoichiometry, in which each of the molecules of a central toxin dimer interact with a dimer of antitoxins. The antitoxin dimers each expose two HTH DNA-binding domains that are structurally similar to the Cro repressor, suggesting that the TA complex is capable of binding the promoter region as observed for most type II TA systems. Surprisingly, the RES domain is not an RNase but shows structural similarity to ADPribosyl transferases (ARTs), a group of enzymes that include the diphtheria toxin (DT) and function by posttranslational modification of their targets. However, we show that the RES toxin has a divergent NAD + -binding pocket suggesting an alternative function. The conserved amino acids R, E and S, which are required for toxin activity in vivo, are tightly coordinated by the C-terminus of the antitoxin, suggesting the antitoxin might prevent binding of NAD + . Finally, we show that activation of the RES toxin in vivo causes a lowering of cellular NAD + levels suggesting that it is active as a NAD + glycohydrolase (NADase).
Results

res-xre loci from several bacterial species function as bona fide type II TA modules
The genetic organization of the P. luminescens res-xre locus complies with that of most type II TA loci with the antitoxin gene (xre) starting with an ATG codon and being located upstream of the toxin gene (res), which has a GTG start codon (Fig. 1A) . The two open reading frames overlap by 4 bp, indicating translational coupling, another common feature of type II TA modules. To investigate if P. luminescens res-xre constitutes a bona fide TA module, gene activities were analyzed by ectopic expression in the standard E. coli K-12 strain, MG1655. First, several plasmid-encoded versions of res were tested with the aim of obtaining different levels of protein expression using an arabinose-inducible promoter:
(1) lowest expression: res with its native Shine-Dalgarno sequence (res naSD ; 5′-GAACACGGAATTGTATC-3′), (2) higher expression: res with an optimized SD (res opSD ; 5′TAAGGAGGAAATTAA-3′) and (3) highest expression: res with an optimized SD and ATG start codon (res opSDatg ). Using a similar strategy, two versions of xre were tested for antitoxin function using an isopropyl β-D-1-thiogalactopyranoside (IPTG)-inducible promoter on a low copy number mini-R1 vector: (1) lowest expression: xre with its native SD (xre naSD ) or (2) higher expression: xre with an optimized SD (xre opSD ). Initially, dilution spot tests showed that optimized translation signals are required for RES to be expressed at a level that inhibits cell growth but also confirmed that this activity can be efficiently neutralized by co-expression of the cognate antitoxin, as both induction of xre naSD and xre opSD rescued cell growth (Fig. 1B) (Fig. 1C, •) . In contrast, induction of xre Pl (at **) allowed full resumption of cell growth after a short lag phase (Fig. 1C, ▪ Pl opSD ) were prepared in LB. At time points indicated by asterisks, 0.2% arabinose (*) was added to induce transcription from P BAD , while 0.2% glucose and 2 mM IPTG (**) were added to repress P BAD and induce P A1/O4/O3 . Growth is expressed as the log of the mean optical density at 600 nm with standard deviations shown as error bars. D. Viable counts. Cultures were prepared as described in C. At time zero, 0.2% arabinose was added to induce P BAD . Cell samples were taken from each culture before (t = 0 h, black columns) and after (t = 1 h, gray columns) protein expression, serially diluted and plated on NA plates containing appropriate antibiotics and either 0.2% glucose or 0.2% glucose and 2 mM IPTG (IPTG). Viability is expressed as the log of the mean number of colony-forming units (CFU) per ml with standard deviations shown as error bars. Fig. S2A and S2B ). In the growth assays, only res Mt opSD could be neutralized by induction of the antitoxin gene ( Fig. S2C and S2D ). In summary, we observe inhibition of cell growth by induction of all res toxin genes in E. coli, while the effect of the antitoxin varies, likely due to the overexpression setup.
The structure of the intact P. putida RES-Xre complex reveals an unusual 2:1 stoichiometry To characterize the res-xre TA system at the molecular level, we decided to determine the three-dimensional structure of the RES-Xre complex by X-ray crystallography. For this purpose, the components encoded by all four TA modules (P. Fig. S3B ). Crystals of the intact RES-Xre complex isolated from the 85 kDa peak that diffracted to 2.2 Å were obtained and the structure was determined ab initio using Se-Met substitution (see Table  2 for crystallographic data statistics and Materials and Methods for details of the structure solution and refinement). The model built using the Se-Met data was subsequently transferred to a native data set extending to the same resolution and refined to crystallographic R factors of 21.4% (R work ) and 25.3% (R free ). The final structure contains four complete Xre antitoxin molecules (residues 1-149) and two complete RES toxin molecules (residues 1-144) per crystallographic asymmetric unit that form a hetero-hexameric and W-shaped assembly with (Xre) 2 -(RES) 2 -(Xre) 2 stoichiometry ( Fig. 2A, left) . The complex has a relatively flat shape with a width of nearly 100 Å and a thickness of only 35 Å ( Fig. 2A , right) and is consistent with interface analysis using the PISA server which suggests that RES 2 Xre 4 as the most stable assembly in solution (Krissinel and Henrick, 2007) . Based on both gel filtration and structural analysis, we thus believe that this hetero-hexamer constitutes the biologically relevant form of the complex. The central core of the RES-Xre TA complex is formed by a homodimer of RES toxin molecules ( Fig. 2A , blue). Each RES monomer is composed of a central, six-stranded, anti-parallel β-sheet linked by four α-helices with an overall fold that can be described as (βα) 3 ββαβ ( Fig. 2B and Fig. 2C ). Dimerization is primarily achieved through interactions between helix α 1 of one monomer and α 2 of the other monomer and between the loops following strands β 4 and β 5 . At this interface, reciprocal hydrogen bond interactions are established between S84 and D141 as well as between S37 residues originating from both monomers (Fig. S4A ). The interaction is further stabilized by hydrophobic interactions involving I112, V47 and M113.
The RES toxin is structurally homologous to the ARTs but has an atypical NAD + -binding pocket
A search for structural homologs using DALI (Holm and Rosenstrom, 2010) reveals that the RES toxin fold is very similar to the catalytic domain of the DT (Z-score 6.9, rmsd 3.5 Å, 12% seq. id., PDB ID 1F0L), a member of the ART family of enzymes (Weiss et al., 1995) . Super-positioning of the structure of RES with the DT catalytic domain reveals that while the peripheral secondary structure elements differ to some extent, there is a conserved structural core in both proteins consisting of the central β sheets that overlay well (Fig. 2D) . ARTs catalyze the transfer of an ADP-ribose moiety from nicotinamide adenine dinucleotide (NAD + ) to a target protein (typically a lysine residue), and although they show poor sequence conservation, the NAD + -binding pocket is structurally well conserved (Han and Tainer, 2002) . ART enzymes are divided into two major groups based on a conserved active-site motif; the HYE motif of the DT group and the RSE motif of the cholera toxin (CT) group, which is involved in NAD + recognition and cleavage (Koch-Nolte et al., 1996; Bazan and Koch-Nolte, 1997) . For the CT group, it was shown that a conserved arginine residue positions NAD + , while a serine residue stabilizes NAD + binding to the pocket (Han et al., 1999 ). An invariant glutamate residue is a key feature among all ARTs and is thought to position NAD + for hydrolysis and coordinate the ADP-ribose transfer (Simon et al., 2014) . A NAD + -binding pocket is also found in the NAD + glycohydrolase (NADase) family of toxins that function by hydrolyzing NAD + without ADP-ribose transfer and for which examples include Streptococcus pyogenes SPN toxin (Ghosh et al., 2010; Smith et al., 2011) , M. tuberculosis necrotizing factor TNT (Sun et al, 2015) , and Pseudomonas aeruginosa Tse6 toxin (Whitney et al., 2015) . All three NADase toxins share a conserved structural core with the ARTs, however, the NAD + -binding pockets are atypical and they do not show any ART activity, the latter being explained by occlusion of the target-binding site by additional structural elements, such as the helical linker in the SPN toxin (Smith et al., 2011) . Despite the overall structural similarity to ARTs, sequence alignment reveals that the conserved activesite residues differ significantly between members of the RES toxin group and known ART/NADase enzymes (Fig. 3A) . More precisely, at the position corresponding to the conserved histidine in the HYE ART and NADase groups (H21 in DT, Fig. 3A , blue star and Fig. 3C ), we find a conserved arginine in RES (R5 in RES Pp , Fig. 3B ), which thus shares more similarity to the RSE ART group (Fig. 3A) . On the other hand, the tyrosine residue of the HYE ART motif (Y54 in DT, Fig. 3A , cyan star and Fig.  3C ), appears to be conserved among RES toxins (Y33 in RES Pp , Fig. 3B ). At the position of a conserved aromatic residue (W/F/Y) in ART enzymes (Fig. 3A, green star) , we find the invariant glutamate of the RES domain (E44 in RES Pp , Fig. 3B ). And finally, there is an asparagine residue (N118) in RES Pp at the position of the conserved glutamate of both ART groups (HYE/RSE, E148 in DT, Fig. 3A ) and the NADases (Fig. 3A , orange star). Except for N118, which is replaced by leucine in RES Mt , all four residues (R, Y, E and N) are conserved among the four RES orthologs included in this study, suggesting they are specific for the RES family. We therefore conclude that the RES toxins, like the NADases, appear to contain atypical residues in the pocket used for NAD + -binding among ART enzymes, suggesting that their function may differ.
The Xre antitoxin contains a Cro-like HTH DNA-binding domain
The P. putida Xre antitoxin displays an exclusively helical fold, consisting of 10 α-helices arranged in a unique structural motif, which is unlike anything found in the PDB (Fig. 4A) . The core fold of the antitoxin is organized around α 7 , which forms a central shaft through the structure onto which three mini-domains α 1-3 , α 4-6 and α 8-10 are anchored. In the context of the RES-Xre complex, each RES molecule of the central toxin dimer associates with a V-shaped homodimer of Xre antitoxin molecules in an unusual 2:1 toxin:antitoxin stoichiometry. This antitoxin dimer is formed through intercalation of the N-terminal half of α 10 of one Xre monomer between α 3 and α 7 of the other (Fig. 4B) and is stabilized by several polar interactions and salt bridges (Fig. S4B) , which appear to be conserved between Xre antitoxins from various species (Fig. S4C) . Interestingly, the mini-domain α 4 -α 6 (residues 43-101) folds as a classical helix-turn-helix (HTH) DNA-binding domain and is structurally similar to the Cro repressor (Brennan and Matthews, 1989) , a feature that was also predicted by comparative sequence analysis (Makarova et al., 2009) . Moreover, the arrangement of the two adjacent Cro domains on the Xre Pp dimer fits surprisingly well with the structure of Cro bound to DNA (PDB ID 1RPE) (Shimon and Harrison, 1993) (Fig. 4C ), suggesting that a dimer of Xre antitoxins can bind DNA promoter in this fashion as a part of the transcriptional regulation of the TA locus. (Fig. 4D) . We note that use of an extended antitoxin C-terminal region for blocking a toxin active site is a common theme among TA modules, which further suggests that this may be a functionally important region of the RES toxin (Page and Peti, 2016; Bendtsen and Brodersen, 2017) . The most significant interactions between toxin and antitoxin involve the last few residues of Xre Pp ; E145, Y147, G148 (Hottiger et al., 2010) . The letters R, E and S indicate the conserved residues identified for the RES domain (Makarova et al., 2009) . The secondary structure observed in the crystal structure of RES Pp is shown above the sequences, with TT indicating a beta turn. Sequence alignments were constrained by structural information using PROMALS3D (Pei and Grishin, 2014) and displayed using ESPript (Gouet et al., 2003) . B. Details of the putative NAD + -binding site in RES Pp with conserved residues shown in blue (putative NAD + -interacting) and green (R, E and S) sticks. The R23A mutation is shown as a gray outline. C. Similar view of the active site of the diphtheria toxin bound to NAD + (PDB ID 1TOX) with catalytically important residues shown as sticks (Bell and Eisenberg, 1996) and L149 (Fig. 4D ). More specifically, the C-terminal carboxylate of the antitoxin (L149) forms a hydrogen bond to the RES Pp N118 side chain, the carbonyl group of G148 interacts with RES Pp E44, Y147 engages in a hydrophobic interaction with RES Pp Y33, and finally, the side chain of E145 on the antitoxin makes a salt bridge to R5 of RES Pp (Fig. 4D ). Taken together, we speculate that these interactions could sterically block access to the putative active site and at the same time engage the conserved residues (R5, Y33 and N118) in tight interactions.
The conserved R, E and S residues of the RES toxin are required for toxicity
The RES domain belongs to the Pfam08808 group for which 1714 sequences are currently registered, almost all of which are proteins belonging to the prokaryotic domain (Finn et al., 2010) . As seen for other bacterial toxins, these protein sequences are highly divergent, with R, E, S, as well as a tyrosine (Y), being the only well-conserved amino acids (Fig. 3A) . In order to understand the functional importance of these conserved residues, we substituted each of the corresponding residues of P. luminiscens RES (R27, Y37, E48 and S117), for which we had confirmed activity of both the toxin and antitoxin in our E. coli system, individually with alanine (A) and tested the effect on growth inhibition. Spot tests showed that the substitutions R27A, E48A and S117A all completely abolished RES-mediated growth inhibition (Fig. 5A) , an observation that was confirmed by growth assays (Fig.  5B) . Thus, the conserved R27, E48 and S117 of RES are required for toxicity, consistent with the proposal that they contribute to an active site. On the contrary, Y37A substitution had little effect on the spot tests ( Fig. 5A ) and no effect on growth inhibition by RES in liquid culture (Fig.  5B) . However, co-expression of the antitoxin (Xre Pl ) did not neutralize toxicity of this mutant (Fig. 5B) , suggesting that Y37 is important for the ability of the antitoxin to interact with the toxin. We note that the effects of the Y37A substitution were not fully borne out by the spot tests, indicating that Y37A might only decrease, but not completely abolish, affinity between the toxin and the antitoxin. Nevertheless, these observations are consistent with the crystal structure of the P. putida TA complex in which Y147 of the antitoxin interacts directly with Y33 (corresponding to Y37 in P. luminescens) of the toxin. Together, these data thus support that the conserved tyrosine (Y33/Y37) is critical for TA interactions but likely not for the function of the catalytic activity of the RES toxin.
Activation of RES lowers NAD + levels in vivo and affects global macromolecular biosynthesis
Based on the presence of a putative NAD + -binding pocket and the functional importance of the conserved residues for toxicity, we hypothesized that RES toxicity could be linked to NAD + degradation as seen for the NADase toxins. We therefore employed a coupled enzyme assay to measure global cellular NAD + levels in MG1655 cells following ectopic expression of the RES toxin (Whitney et al., 2015) . As compared to an empty vector control, an almost complete depletion of NAD + was observed in cells expressing in RES Pl (Fig. 5C , 'res/-' and S5A), while the level was partly restored upon co-expression of the Xre Pl antitoxin (Fig. 5C , 'res/xre' and S5B Fig. 1C . Empty plasmid vectors were included as controls (−/−). At the time points indicated by asterisks, 0.2% arabinose (*) was added to induce transcription from the P BAD promoter, while 0.2% glucose and 2 mM IPTG (**) were added to repress transcription from the P BAD promoter and induce transcription from the P A1/O4/O3 promoter. The growth is expressed as the log of the mean optical density at 600 nm with standard deviations shown as error bars. C. Relative intracellular NAD + levels were measured in MG1655 upon expressing of the res Pl toxin alone (res/−), the res Pl toxin and xre Pl antitoxin together (res/xre), or the nontoxic res Pl R27A toxin alone (res Pl R27A /−). For each culture, the pBAD33 vector was induced alone (arabinose) or simultaneously with the pKW220 vector (arabinose + IPTG). NAD + levels were assayed every fifth minute after protein expression for 50 min. NAD + levels were determined as the slope of the luciferin signal from the linear range of the assay and normalized to an empty vector control strain. The columns show the means of three independent experiments with standard deviations indicated by the error bars.
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for full restoration of growth, and thus consistent with an overall bacteriostatic toxin effect. Finally, the NAD + level in cells expressing the nontoxic RES Pl R27A variant was the same as in the control, confirming the importance of this residue for toxin activity. Together, these results support a model in which toxicity of RES is linked to depletion of cellular NAD + as seen for the NADase toxins.
Finally, to understand the wider, cellular effects of NAD + depletion during toxin activation, we used pulsechase methodology to follow cellular incorporation of 5′-3 H-uridine, 35 S-methionine or 3 H-methyl-thymidine to measure the global rates of transcription, translation or replication, respectively, after expression of res Pl in E.
coli. All three processes were eventually affected, but in a distinct pattern, whereby the rate of transcription dropped fastest (Fig. 6A) , followed by replication (Fig. 6B ) and translation considerably later (Fig. 6C) . The effect on transcription could be confirmed for res Ye and res Mt but was less pronounced for res Mt (Fig. 6D) . In summary, we find that activation of the RES toxin appears to negatively affect the capability of the cell to synthesize DNA, RNA and protein. This effect is likely an indirect result of the depletion of NAD + but the exact molecular details of the RES-type toxins remain to be worked out.
Discussion
In this paper, we present the first detailed functional and structural study of the RES-Xre domain TA modules. We demonstrate that the P. luminescens COG5654-COG5642 (RES-Xre) locus constitutes a bona fide type II TA system in E. coli, encoding a toxic protein that inhibits cell growth and an antitoxic protein that counteracts this function in vivo. We show that these functions are conserved for other similar loci in both Gram-negative and Gram-positive bacteria and we identify several conserved and functionally important residues in the RES toxin. The crystal structure of the intact P. putida RESXre complex revealed an unusual RES 2 Xre 4 architecture consisting of a central toxin dimer each bound to an antitoxin dimer. Analysis of the toxin fold and putative activesite region showed that the toxin is structurally similar to the family of ART enzymes but has an atypical NAD + -binding site with which the antitoxin interacts directly. We show that the antitoxin contains a DNA-binding domain of the helix-turn-helix type with structural similarity to the Cro repressor, suggesting that the TA complex can bind and regulate transcription from its own promoter as seen for many type II TA systems. Finally, we demonstrate that activation of the RES toxin reduces global NAD + levels in Pl was induced with 0.2% arabinose (res Pl ). As a control, an MG1655 culture was left uninduced (control), while another culture was treated with antibiotics targeting either transcription (rifampicin), replication (ciprofloxacin) or translation (chloramphenicol). Cell samples were collected at the time points indicated and pulsed in 1 min with radiolabeled uridine (A) to determine the rate of transcription, methionine (B), to determine the rate of translation, or thymidine (C), to determine the rate of replication. In addition, the effects of res Ye and res Mt on transcription as compared to res Pl were measured (D) in a similar setup. Rates of transcription, translation and replication were calculated from three independent experiments, with resulting standard deviations shown as error bars. Values were normalized to cell density (OD 600 ) and time zero rates were set to 100%.
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vivo and that several major cellular pathways are affected as a result of this, most markedly transcription. The observation that the RES toxin is structurally related to the ART and NADase toxins was surprising and demonstrates that the range of toxin targets in bacteria is much wider than previously appreciated. What differentiates these two groups of enzymes (ARTs and NADases), is the ability of ARTs to transfer an ADP-ribose unit from NAD + to a target protein. The details of how this happens have been revealed by structures of e.g. the iota toxin bound to a NAD + analog and its target protein, actin (Tsuge et al., 2008) and exotoxin A bound to elongation factor eEF2 (Jørgensen et al., 2005) . These structures have shown that in order for the toxin to access its target, the ART active site has to be relatively exposed (Fig.  S6A) . On the contrary, the structure of the NADase toxin SPN revealed that in this case, a helical linker region protruding from the toxin near the NAD + -binding site effectively prevents binding of target molecules, causing this enzyme to function as a NADase rather than an ART (Fig. S6B) (Smith et al., 2011) . Comparison to RES (Fig.  S6C ) and the structurally similar diphtheria toxin (DT, Fig.  S6D ), which is an ART like the iota toxin and exotoxin A, reveals that residues 77-100 of RES appear to form a helical extension to the core fold located in a place similar to the SPN helical linker. Thus, the active site is less exposed in RES than in DT, suggesting it may not be able to access a target and consequently that it may be an NAD + -degrading toxin rather than an ART.
Cell division in E. coli is known to require a minimal concentration of NAD + , which supports that the activity of RES could be bacteriostatic rather than bactericidal (Zhou et al., 2011) . Common for the NADase toxins, SPN (Ghosh et al., 2010; Smith et al., 2011) , TNT (Sun et al, 2015) , and Tse6 (Whitney et al., 2015) , is that they all function as virulence factors, inducing either cell stasis or cell death upon transfer into the host environment. For example, the M. tuberculosis TNT toxin kills infected macrophages by depleting them for NAD + (Sun et al., 2015) , while the P. aeruginosa Tse6 toxin acts bacteriostatically on target cells by degrading NAD + and NADH (Whitney et al., 2015) . Another factor with NAD(P) + -hydrolyzing activity is the recently described Tne2 toxin from P. protegens Pf-5, which plays an important role in interbacterial killing by this pathogen (Tang et al., 2018) . Interestingly, all these NADases have so-called immunity proteins that bind to and block access of NAD + in a similar way to antitoxins to protect the bacteria from self-poisoning. Thus, modulation of host NAD + levels seems to be a widespread virulence strategy among bacterial pathogens. P. luminescens is both a nematode symbiont and an insect pathogen, with death of the infected insect being a critical part of its life cycle (Clarke, 2008) . In order to kill its host, the bacterium produces a wide array of non-TA toxins, several of which consume NAD + (Dowling, 2017) .
Examples are the CT-like ART toxin Photox (Visschedyk et al., 2010) and the TccC3 and TccC5 toxin components of the Photorhabdus Tc toxin complexes 3 and 5 (Lang et al., 2010) . Both are ART toxins of the CT class containing the classical RSE motif, and are transported into target cells where they affect actin polymerization. We therefore speculate that the RES-Xre TA system could play a role in pathogenicity of P. luminescens during insect infection. However, it is also possible that the RESXre system is used by P. luminescens to fine-tune intracellular energy levels during infection in response to yet unidentified activation signals.
The structure of RES-Xre demonstrated that the TA complex forms a hetero-hexameric, W-shaped assembly on the form (Xre) 2 -(RES) 2 -(Xre) 2 . This unusual 1:2 toxin:antitoxin stoichiometry is to our knowledge unprecedented among TA systems. TA higher order structure is usually related to DNA-binding and transcriptional regulation, but the principles of regulation of the res-xre operon, including the mechanisms of repression/de-repression, are not known. In general, however, type II antitoxins are composed of two separate domains; an N-terminal DNAbinding domain and a C-terminal toxin-binding domain (Chan et al., 2016) . The C-terminus is usually natively unstructured until formation of the TA complex, making the free antitoxin labile and susceptible to degradation by host proteases, such as Lon or ClpP (Muthuramalingam et al., 2016) . A hallmark of type II TA operons is transcriptional autoregulation, in which two DNA-binding domains (each formed by dimerization of the N-terminal domains from two antitoxin molecules of the TA complex) come together to bind to one or more promoter upstream operators of the TA operon, thereby repressing transcription . The discovery of an HTH DNA-binding motif in Xre
Pp with structural similarity to the Cro repressor strongly suggests that the antitoxin is able to bind DNA, and thus likely can regulate TA expression through promoter binding (Harms et al., 2018) . The HigA antitoxin of the HigAB TA system has a similar HTH DNA-binding domain, which allows it to bind its DNA operator sequence (Schureck et al., 2014) . Compared to other TA modules, each Xre antitoxin contains a complete DNA-binding domain, while in many other cases, including RelBE and VapBC, antitoxin dimerization is required to form a single domain. This means that the (Xre) 2 -(RES) 2 -(Xre) 2 complex contains a total of four DNA-binding domains, which is intriguing and could indicate that it binds the TA promoter in a hitherto uncharacterized fashion, possibly involving a second promoter binding site. Super-positioning of the structure of the Cro repressor bound to DNA on both antitoxin dimers (Fig. S6E ) reveals that the DNA strands are not aligned on their axis when superimposed on both binding regions and thus that a conformational change of either the TA complex or the DNA would be required for the complex to bind such a quadruple site on DNA. Future structural and function studies will thus be required to fully elucidate the regulation and activation of the RES-Xre type TA system.
Experimental procedures
Growth conditions and media E. coli cultures were grown on nutrient agar (NA) plates supplemented with appropriate antibiotics, or in Luria-Bertani (LB) media at 37°C. In some experiments, E. coli was grown in M9 minimal medium supplemented with appropriate amino acids and 0.5% glycerol as carbon source. When applicable, media was supplemented with 50 μg ml −1 chloramphenicol, 1 μg ml −1 ciprofloxacin, 50 μg ml −1 rifampicin, or 30 or 100 μg ml −1 ampicillin. Expression from the P BAD promoter was repressed by addition of 0.2% glucose or induced by addition of 2% arabinose. Expression from the P A1/O4/O3 promoter and from pET28a was induced by addition of 2 mM IPTG.
Bacterial strains and plasmids
Bacterial strains and plasmids used in this study are listed in Tables S1 and S2 respectively. The res toxin and xre antitoxin genes were amplified by PCR from their genomes of origin or from DNA fragments synthesized by GenScript. DNA templates are listed in Table S2 and PCR primers are listed in Table S3 . Since the genome of M. tuberculosis is particularly GC rich and has a strong preference for codons ending with C and G (Andersson and Sharp, 1996) , the resxre Mt module was codon-optimized before expression in E. coli (see Supplementary Data for the optimized sequences). The res toxins were cloned into pBAD33 (Guzman et al., 1995) under control of the P BAD promoter and either the native (na) or an optimized (op) Shine-Dalgarno (SD) sequence (5′-TAAGGAGGAAATTAA-3′) was included at 5′ end of the construct. The opSD sequence encodes a strong SD (5′-UAAGGAGG-3′) (Ringquist et al., 1992) and additional A and U nucleotides to optimize translation. The xre antitoxin genes were cloned into pKW220 (laboratory plasmid, unpublished) under the control of a particularly tight promoter, P A1/O4/O3 .
For recombinant expression and purification of the RES toxins, the genes were either co-expressed with a His 6 -tagged Xre antitoxin from pMG25 (laboratory plasmid) under the control of the P A1/O4/O3 promoter or expressed alone from the commercial expression vector pET28a (Novagen). For P. luminescens res, both native and nontoxic mutants were tested, while for the other species, only nontoxic res mutants were tested. Inserts for pMG25 were constructed in silico, synthesized by Genscript and delivered in pUC57 vectors, while the inserts for pET28a were amplified by PCR as described in Table S2 . All plasmids were cloned and stored in E. coli DH5α, using standard procedures of restriction-based cloning. The restriction enzymes are listed in Table S2 . All plasmids constructions were confirmed by DNA sequencing, using the sequencing primers listed in Table  S3 , and transformed into E. coli MG1655 or derivatives of BL21 for experimental analysis and recombinant protein expression.
Mutagenesis
The four conserved amino acids of P. luminescens RES; R27, E48, S117 and Y37, were substituted individually for alanine (A) to test their importance for toxicity. Moreover, the conserved R23 of P. putida RES Pp was substituted for A prior to protein purification and structure determination, to allow overexpression of the toxin. DNA constructs were constructed in silico to contain appropriate mutations, synthesized by GenScript, and delivered in pUC57 vectors, ready for subsequent cloning and analysis.
Toxicity assays and viable counts
Toxin-antitoxin activity assays were carried out in E. coli MG1655 containing appropriate pBAD33 and pKW220 constructs. TA activity was assayed by (1) spotting on NA plates, (2) growth assays and (3) viable counts. For the spots, overnight cultures containing glucose to repress the P BAD promoter were diluted to OD 600 = 1 into phosphate buffered saline (PBS) and serial 10-fold dilutions were prepared. Spots of 3 μl were spotted on NA plates containing appropriate antibiotics. Plates were supplemented with glucose, arabinose or arabinose + IPTG as indicated.
For the growth assays and viable counts, overnight cultures containing glucose were diluted to OD 600 0.03 (~1:100 dilution) into fresh LB medium with appropriate antibiotics and grown to exponential phase (OD 600 ~0.2-0.3) after which arabinose was added to induce transcription from the P BAD promoter. After 60-80 min, transcription was repressed by the addition of glucose and simultaneously, IPTG was added to induce transcription from the P A1/O4/O3 promoter. Samples for OD 600 measurements and viable counts were taken at the time points indicated. For the viable counts, samples were diluted 10-fold in PBS and 100 μl of selected dilutions were plated in duplicates on NA plates containing appropriate antibiotics. Plates were supplemented with glucose, arabinose or arabinose + IPTG as indicated. Bacterial cell survival was expressed as the number of colony-forming units (CFU) per ml. Assays were repeated in at least three independent experiments, and the viable count calculations of the mean and standard deviation (SD) were performed with GraphPad Prism (GraphPad Software Inc.).
Protein purification
pET28a::res PpR23A and pMG25::xre Pp ::res PpR23A were transformed into E. coli BL21 CodonPlus RIL (DE3) cells (Agilent) or the Met auxotroph strain E. coli BL21 B834 (DE3) (Merck) for seleno-methionine (Se-Met) incorporation. E. coli cells were grown in LB medium at 37°C to an OD 600 of 0.6-0.8 and induced by addition of 1 mM IPTG for 3 h at 37°C. Cells were harvested by centrifugation (6000 rpm, 15 min at 4°C). Se-Met labeled protein expressed from pMG25::xre Pp ::res Pp R23A was achieved using Se-Met Medium Complete (Molecular Dimensions), growing at 37°C to an OD 600 of 0.6-0.8, followed by induction with 0.1 mM IPTG for 15 h at 20°C. Cell pellets were resuspended in a lysis buffer (50 mM Tris-HCl, pH 8.5, 150 mM NaCl, 150 mM KCl and 5 mM imidazole), followed by sonication and clarification by centrifugation (14,000 rpm, 30 min). Cell extracts with the His 6 -TEV-Xre Pp :RES Pp R23A complex (both native and Se-Met labeled) or RES Pp R23A were loaded onto a prepacked 5 ml Ni-NTA super-flow (Qiagen) or 1 ml His-Trap columns (GE Healthcare) respectively. After binding, a two-step wash was performed using a wash buffers identical to the lysis buffer but including 10 or 30 mM imidazole, respectively, after which proteins were eluted using 300 mM imidazole. RES Pp R23A was further purified using a 1 ml Source 15Q column (GE Healthcare) running in 50 mM Tris-HCl, pH 8.5, 5 mM β-mercaptoethanol and a gradient into 1 M NaCl. Final separation was achieved on a Superdex 75 10/300 GL column (GE Healthcare), equilibrated in 20 mM Tris-HCl, pH 7.5, 150 mM NaCl and 5 mM β-mercaptoethanol. The His 6 -TEVXre Pp :RES Pp R23A complex was incubated with recombinant TEV protease to a final concentration of 0.1 mg ml −1 and incubated for 12 h at 4°C to remove the His 6 tag, and further purified on a 1 ml Source 15Q column (GE Healthcare) running in 50 mM Tris-HCl, pH 8.5, 5 mM β-mercaptoethanol, 300 mM imidazole and a gradient into 1 M NaCl. Inclusion of 300 mM imidazole was necessary to stabilize the protein complex which otherwise would precipitate. Peak fractions were pooled and concentrated using a mini-spin column before loading on a Superdex 200 increased 10/300 GL column (GE Healthcare), equilibrated in 20 mM Tris-HCl, pH 7.5, 150 mM KCl, 150 mM NaCl, 300 mM imidazole and 5 mM β-mercaptoethanol. Peak fractions were analyzed on a precast protein gel (Bio Rad) and concentrated to 4 mg ml −1 prior to crystallization assays.
Structure determination
Both Se-Met labeled and native Xre Pp :RES PpR23A complex crystallized at 19°C in sitting drops. Orthorhombic crystals belonging to the space group P2 1 2 1 2 1 appeared in 0.10% w/v n-octyl-β-D-glucoside, 0.1 M sodium citrate tribasic dihydrate, pH 5 and 22% w/v polyethylene glycol 3350 (Se-Met), and 0.2 M sodium malonate, pH 6.0 and 20% w/v polyethylene glycol 3350 (native). Crystals were cryo-protected in these conditions by supplementing with 30% (v/v) glycerol and immediately flash-cooled in liquid nitrogen. A complete Se-Met SAD data set was collected at ESRF ID29 and phases obtained using SHELXD/hkl2map pipeline (Sheldrick, 2010) . The structure was built manually based on the initial model from hkl2map and iteratively refined in phenix.refine (Adams et al., 2010 ). The refined model was then used to solve the structure of the native Xre Pp :RES PpR23A complex at 2.2 Å by molecular replacement. Ramachandran outliers were corrected by hand in Coot and clashes were corrected using Namdinator program (developed by Rune Thomas Kidmose, Aarhus University, https://github.com/ rukibuki/namdinator).
NAD
+ depletion assay E. coli MG1655 cultures containing appropriate pBAD33 and pKW220 constructs were prepared in LB medium. As control, a strain with empty vectors was included. Overnight cultures, containing 0.2% glucose to repress the P BAD promoter, were diluted to OD 600 0.01 into fresh LB medium and grown to OD 600 of 0.3-0.4. Induction of protein expression was done with (1) arabinose or (2) arabinose + IPTG. Onehour post-induction, cultures were diluted to OD 600 0.5 and 500 μl was collected by centrifugation and resuspended in 50 μl PBS. To normalize measurements against background signal, a PBS-only sample was included. Cells were lysed in 0.2 M NaOH + 1% (w/v) cetyltrimethylammonium bromide (CTAB, Sigma), followed by treatment with 0.4 M HCl at 60°C for 15 min. Samples were neutralized with 0.5 M Tris base and mixed with an equal amount of NAD + /NADH-Glo TM Detection Reagent (Promega). Luciferin bioluminescence was measured continuously every fifth min for 50 min, using a microplate reader (SpectraMax i3, Molecular Devices), and normalized to background (PBS-only) signal for each time point. Relative NAD + concentrations were determined using the slope of the luciferin signal from the linear range of the assay as compared with the empty vector control strain.
Pulse-chase experiments
E. coli MG1655 cultures containing appropriate pBAD33 constructs were prepared in M9 minimal medium containing all amino acids except methionine. Overnight cultures, containing glucose to repress the P BAD promoter, were diluted to OD 450 0.005 (~1:500 dilution) into fresh M9 minimal medium and grown to exponential phase (OD 450 ~0.3-0.4). At time zero, arabinose was added to the cultures to induce transcription from the P BAD promoter. As a positive control, E. coli MG1655 cultures treated with either rifampicin (transcription), chloramphenicol (translation) or ciprofloxacin (replication). As a negative control, non-treated E. coli MG1655 cultures were included. Pulse-chase experiments were carried out as described in (Winther et al., 2013) . For the pulses, radiolabeled 35 S-methionine (5 μCi), 3 H-methylthymidine (2 μCi) or 5-3 H-uridine (2 μCi) was used, together with 20-fold excess of unlabeled methionine, thymidine or uridine as carriers. For the chases, 50 μl of a 50 mg ml −1 stock solution of unlabeled methionine, thymidine or uridine was used. The incorporation of radioisotopes was measured in triplicates by liquid scintillation counting. The rates of transcription, translation or replication were calculated as the mean counts per minute and adjusted for differences in cell densities (OD 450 values), with the time zero value set to 100%. All pulse-chase experiments were repeated in three independent experiments and calculations of the mean and standard deviation were performed with GraphPad Prism (GraphPad Software Inc.). 
